Bourgeon Capital Management LLC Sells 571 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Bourgeon Capital Management LLC reduced its stake in Intuitive Surgical by 43.6%, selling 571 shares during the second quarter, leaving it with 740 shares valued at approximately $402,000.
• Several institutional investors have increased their positions in Intuitive Surgical, with 83.64% of the stock now owned by such investors, reflecting growing interest in the company.
• Analyst ratings on Intuitive Surgical are mixed, with a consensus rating of "Moderate Buy" and an average target price of $595.95, while key firms like Deutsche Bank maintain a "sell" rating.

Bourgeon Capital Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 43.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 740 shares of the medical equipment provider's stock after selling 571 shares during the quarter. Bourgeon Capital Management LLC's holdings in Intuitive Surgical were worth $402,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Chilton Capital Management LLC grew its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical during the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. TD Capital Management LLC grew its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ISRG shares. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Evercore ISI increased their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Trading Down 0.4%

Shares of NASDAQ:ISRG opened at $439.22 on Tuesday. The stock has a fifty day simple moving average of $467.89 and a two-hundred day simple moving average of $501.35. The stock has a market capitalization of $157.45 billion, a price-to-earnings ratio of 61.26, a PEG ratio of 4.62 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.78 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company's stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.